AOXG Statistics
Total Valuation
Aoxing Pharmaceutical Company has a market cap or net worth of 2.74 million.
| Market Cap | 2.74M |
| Enterprise Value | n/a |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
Aoxing Pharmaceutical Company has 381.21 million shares outstanding.
| Current Share Class | n/a |
| Shares Outstanding | 381.21M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.02 |
| PB Ratio | 0.03 |
| P/TBV Ratio | 0.16 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.79, with a Debt / Equity ratio of 1.53.
| Current Ratio | 0.79 |
| Quick Ratio | 0.51 |
| Debt / Equity | 1.53 |
| Debt / EBITDA | 14.19 |
| Debt / FCF | -19.89 |
| Interest Coverage | 0.33 |
Financial Efficiency
Return on equity (ROE) is -7.56% and return on invested capital (ROIC) is 1.30%.
| Return on Equity (ROE) | -7.56% |
| Return on Assets (ROA) | 1.00% |
| Return on Capital (ROIC) | 1.30% |
| Revenue Per Employee | 87,010 |
| Profits Per Employee | -4,229 |
| Employee Count | 346 |
| Asset Turnover | 0.50 |
| Inventory Turnover | 2.32 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +11.84% in the last 52 weeks. The beta is -57.62, so Aoxing Pharmaceutical Company's price volatility has been lower than the market average.
| Beta (5Y) | -57.62 |
| 52-Week Price Change | +11.84% |
| 50-Day Moving Average | 0.01 |
| 200-Day Moving Average | 0.01 |
| Relative Strength Index (RSI) | 46.28 |
| Average Volume (20 Days) | 46,301 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.04 |
Income Statement
In the last 12 months, Aoxing Pharmaceutical Company had revenue of 30.11 million and -1.46 million in losses. Loss per share was -0.02.
| Revenue | 30.11M |
| Gross Profit | 22.94M |
| Operating Income | 967,218 |
| Pretax Income | -1.87M |
| Net Income | -1.46M |
| EBITDA | 1.95M |
| EBIT | 967,218 |
| Loss Per Share | -0.02 |
Balance Sheet
The company has 7.08 million in cash and 27.72 million in debt, giving a net cash position of -20.64 million or -0.05 per share.
| Cash & Cash Equivalents | 7.08M |
| Total Debt | 27.72M |
| Net Cash | -20.64M |
| Net Cash Per Share | -0.05 |
| Equity (Book Value) | 18.09M |
| Book Value Per Share | 0.25 |
| Working Capital | -9.17M |
Cash Flow
In the last 12 months, operating cash flow was -1.36 million and capital expenditures -30,267, giving a free cash flow of -1.39 million.
| Operating Cash Flow | -1.36M |
| Capital Expenditures | -30,267 |
| Free Cash Flow | -1.39M |
| FCF Per Share | -0.00 |
Margins
Gross margin is 76.19%, with operating and profit margins of 3.21% and -4.86%.
| Gross Margin | 76.19% |
| Operating Margin | 3.21% |
| Pretax Margin | -6.21% |
| Profit Margin | -4.86% |
| EBITDA Margin | 6.49% |
| EBIT Margin | 3.21% |
| FCF Margin | n/a |
Dividends & Yields
Aoxing Pharmaceutical Company does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -5.60% |
| Shareholder Yield | -5.60% |
| Earnings Yield | -266.69% |
| FCF Yield | -50.78% |
Stock Splits
The last stock split was on March 29, 2010. It was a reverse split with a ratio of 0.5.
| Last Split Date | Mar 29, 2010 |
| Split Type | Reverse |
| Split Ratio | 0.5 |
Scores
Aoxing Pharmaceutical Company has an Altman Z-Score of -0.33. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.33 |
| Piotroski F-Score | n/a |